RankingsPricing
  1. US-listed companies
  2. LIGAND PHARMACEUTICALS INC

LIGAND PHARMACEUTICALS INCLGND

Market cap
$1.9B
P/E ratio
35.9x
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and cash equivalents712121609719211177248204523
Short-term investments10-47103122181601940364322167147
Accounts receivable, net--------3057853033
Inventory12102247726271324
Income taxes receivable--------112656
Other current assets11122222054533
Prepaid expenses------------1
Other current assets11122222054533
Total current assets3224251852161632378711,124501465264237
Deferred income taxes, net------844726243490
Intangible assets, net5756535148205229220210595551342300
Goodwill151212121272868795190181106103
Commercial License Rights--5592620312011101067
Property and equipment, net01100245714211216
Operating lease assets--------10717116
Finance lease assets---------161643
Other assets1100025024356
Equity Method Investments----3086-----13
Other investments------------36
Total assets1221041052585346026711,2611,4951,3621,298763787
Other assets1100025024356
Total assets1221041052585346026711,2611,4951,3621,298763787
Accounts payable11648432424852
Accrued liabilities8555567191019181612
Current contingent liabilities702710556340300
Deferred revenue-------32291101
Current operating lease liabilities---------2210
Current finance lease liabilities---------7000
Convertible Debt, Current-----21322526---77-
Total current liabilities44352923212272398217100429917
Total current liabilities44352923212272398217100429917
Convertible Debt, Noncurrent-------610639442321--
Long-term deferred revenue3222--4-----1
Long-term contingent liabilities1111128339769833
Deferred income taxes, net--------3365593132
Long-term operating lease liabilities--------10615106
Other long-term liabilities011101112231312228
Total liabilities105785523423023125270072865347616586
Total liabilities105785523423023125270072865347616586
Common Stock, Value, Issued0000000000000
Additional paid-in capital733752718681701770798791367318373148199
Accumulated other comprehensive loss--35532-1-0-1-1-1-1
Retained earnings-682-683-671-659-402-431-401-229400392449451503
Total stockholders’ equity-265026304341400561767710821597701
Common Stock, Value, Issued0000000000000
Additional paid-in capital733752718681701770798791367318373148199
Accumulated other comprehensive loss--35532-1-0-1-1-1-1
Retained earnings-682-683-671-659-402-431-401-229400392449451503
Total stockholders’ equity-265026304341400561767710821597701
Total liabilities and stockholders’ equity1221041052585346026711,2611,4951,3621,298763787
Total liabilities and stockholders’ equity1221041052585346026711,2611,4951,3621,298763787